SK82399A3 - Heteroaryl sulfonamide compounds, process for their preparation, pharmaceutical compositions containing them and their use - Google Patents
Heteroaryl sulfonamide compounds, process for their preparation, pharmaceutical compositions containing them and their use Download PDFInfo
- Publication number
- SK82399A3 SK82399A3 SK823-99A SK82399A SK82399A3 SK 82399 A3 SK82399 A3 SK 82399A3 SK 82399 A SK82399 A SK 82399A SK 82399 A3 SK82399 A3 SK 82399A3
- Authority
- SK
- Slovakia
- Prior art keywords
- benzodioxan
- ylmethyl
- methyl
- chloro
- piperidyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Light Receiving Elements (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9627006.1A GB9627006D0 (en) | 1996-12-27 | 1996-12-27 | Therapeutic agents |
PCT/EP1997/007034 WO1998029411A1 (en) | 1996-12-27 | 1997-12-15 | Sulfonamide compounds having 5-ht receptor activity |
Publications (1)
Publication Number | Publication Date |
---|---|
SK82399A3 true SK82399A3 (en) | 2000-05-16 |
Family
ID=10805084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK823-99A SK82399A3 (en) | 1996-12-27 | 1997-12-15 | Heteroaryl sulfonamide compounds, process for their preparation, pharmaceutical compositions containing them and their use |
Country Status (19)
Country | Link |
---|---|
US (1) | US6136825A (ja) |
EP (1) | EP0948498A1 (ja) |
JP (1) | JP2001508419A (ja) |
KR (1) | KR20000062356A (ja) |
CN (1) | CN1247537A (ja) |
AU (1) | AU747545B2 (ja) |
BG (1) | BG103557A (ja) |
BR (1) | BR9714237A (ja) |
CA (1) | CA2275668A1 (ja) |
GB (1) | GB9627006D0 (ja) |
HU (1) | HUP0000489A3 (ja) |
IL (1) | IL130361A0 (ja) |
NO (1) | NO993172L (ja) |
NZ (1) | NZ336328A (ja) |
PL (1) | PL334254A1 (ja) |
SK (1) | SK82399A3 (ja) |
TR (1) | TR199901478T2 (ja) |
WO (1) | WO1998029411A1 (ja) |
ZA (1) | ZA9711551B (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001514663A (ja) | 1997-03-12 | 2001-09-11 | エスモンド,ロバート ダブリュー. | アルツハイマー病を処置または予防するための方法 |
GB9915617D0 (en) * | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
SE0002739D0 (sv) * | 2000-07-21 | 2000-07-21 | Pharmacia & Upjohn Ab | New use |
US6399617B1 (en) | 2000-07-21 | 2002-06-04 | Biovitrum Ab | Use |
WO2005080394A1 (en) * | 2004-02-24 | 2005-09-01 | Bioaxone Therapeutique Inc. | 4-substituted piperidine derivatives |
US20080299674A1 (en) * | 2004-07-14 | 2008-12-04 | Yoshikazu Kitano | Novel Isonitrile Compound, Its Method Of Manufacture, A Marine Fouling Organism Larva Fluorescent, And A Method Of Detecting This Marine Fouling Organism Larva Using Said Marker |
PT1831159E (pt) * | 2004-12-21 | 2010-03-03 | Hoffmann La Roche | Derivados de tetralina e de indano e as suas utilizações |
PL395470A1 (pl) | 2011-06-29 | 2013-01-07 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Sulfonamidowe pochodne amin alicyklicznych do leczenia chorób osrodkowego ukladu nerwowego |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
US5300523A (en) * | 1988-07-28 | 1994-04-05 | Bayer Aktiengesellschaft | Substituted aminomethyltetralins and their heterocyclic analogues |
FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
FR2701479B1 (fr) * | 1993-02-11 | 1995-05-12 | Pf Medicament | Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique. |
GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
-
1996
- 1996-12-27 GB GBGB9627006.1A patent/GB9627006D0/en active Pending
-
1997
- 1997-12-15 US US09/331,066 patent/US6136825A/en not_active Expired - Lifetime
- 1997-12-15 NZ NZ336328A patent/NZ336328A/xx unknown
- 1997-12-15 HU HU0000489A patent/HUP0000489A3/hu unknown
- 1997-12-15 CA CA002275668A patent/CA2275668A1/en not_active Abandoned
- 1997-12-15 JP JP52957498A patent/JP2001508419A/ja active Pending
- 1997-12-15 CN CN97181916A patent/CN1247537A/zh active Pending
- 1997-12-15 EP EP97953819A patent/EP0948498A1/en not_active Withdrawn
- 1997-12-15 BR BR9714237-9A patent/BR9714237A/pt not_active IP Right Cessation
- 1997-12-15 PL PL97334254A patent/PL334254A1/xx unknown
- 1997-12-15 IL IL13036197A patent/IL130361A0/xx unknown
- 1997-12-15 SK SK823-99A patent/SK82399A3/sk unknown
- 1997-12-15 WO PCT/EP1997/007034 patent/WO1998029411A1/en not_active Application Discontinuation
- 1997-12-15 TR TR1999/01478T patent/TR199901478T2/xx unknown
- 1997-12-15 KR KR1019997005840A patent/KR20000062356A/ko not_active Application Discontinuation
- 1997-12-15 AU AU57580/98A patent/AU747545B2/en not_active Ceased
- 1997-12-23 ZA ZA9711551A patent/ZA9711551B/xx unknown
-
1999
- 1999-06-25 NO NO993172A patent/NO993172L/no not_active Application Discontinuation
- 1999-07-06 BG BG103557A patent/BG103557A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB9627006D0 (en) | 1997-02-12 |
IL130361A0 (en) | 2000-06-01 |
ZA9711551B (en) | 1999-06-23 |
HUP0000489A2 (hu) | 2000-12-28 |
US6136825A (en) | 2000-10-24 |
HUP0000489A3 (en) | 2001-06-28 |
NZ336328A (en) | 2000-09-29 |
AU5758098A (en) | 1998-07-31 |
CN1247537A (zh) | 2000-03-15 |
WO1998029411A1 (en) | 1998-07-09 |
PL334254A1 (en) | 2000-02-14 |
CA2275668A1 (en) | 1998-07-09 |
NO993172D0 (no) | 1999-06-25 |
NO993172L (no) | 1999-06-25 |
JP2001508419A (ja) | 2001-06-26 |
BR9714237A (pt) | 2000-04-18 |
BG103557A (en) | 2000-06-30 |
TR199901478T2 (xx) | 1999-09-21 |
EP0948498A1 (en) | 1999-10-13 |
KR20000062356A (ko) | 2000-10-25 |
AU747545B2 (en) | 2002-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6353002B2 (en) | Therapeutic agents | |
DE69619704T2 (de) | Heteroacylcarbonsäureamiderivate | |
HRP960349A2 (en) | Therapeutic agents | |
PL194118B1 (pl) | Związki N-arylopiperydyny, sposób wytwarzania związków N-arylopiperydyny, oraz kompozycje farmaceutyczne zawierające te związki | |
US6218405B1 (en) | Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them | |
US6391891B1 (en) | Bicyclic compounds as ligands for 5-HT1 receptors | |
SK2498A3 (en) | Heterocyclylcarboxamide derivatives and their use as therapeutic agents | |
HU208817B (en) | Process for producing thiazine- /or oxazine derivatives condensed with carbocyclic and producing medical preparatives containing it | |
SK82399A3 (en) | Heteroaryl sulfonamide compounds, process for their preparation, pharmaceutical compositions containing them and their use | |
JP4890268B2 (ja) | ベンゾピラン誘導体、これの生産方法、およびこれの使用 | |
KR100425953B1 (ko) | 티오피란유도체 | |
EP1572672B1 (en) | Benzoxazocines and their use as monoamine-reuptake inhibitors | |
NO309477B1 (no) | Nye heterocykliske aminometylforbindelser, fremgangsmåte ved fremstilling av dem og farmasöytiske sammensetninger som inneholder dem | |
BG108531A (bg) | Нови х...'...роарилни производни, 'яхно'о пол"-аван... и използван... | |
HU224312B1 (hu) | 2-Amino-indán-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
WO2001072741A2 (en) | N-benzodioxanylmethyl-1-piperidyl-methylamine compounds for the treatment of central nervous system disorders | |
MXPA02005485A (es) | Compuestos triciclicos y metodo de tratamiento del virus del herpes. | |
SK17602000A3 (sk) | N-benzodioxanylmetyl-1-piperidyl-metamínové zlúčeniny majúce afinitu k 5-ht receptorom | |
MXPA99005997A (en) | Sulfonamide compounds having 5-ht receptor activity | |
KR840001095B1 (ko) | 2, 4-디아미노퀴나졸린 화합물의 제조 방법 | |
CZ232799A3 (cs) | Sulfonamidové sloučeniny s aktivitou receptorů 5-HT | |
DK150305B (da) | Analogifremgangsmaade til fremstilling af tetrahydrothiopyrano (3,2-b)indol-derivater | |
RU1836345C (ru) | Способ получени полициклических биоцидных соединений или их солей | |
KR100254665B1 (ko) | 신경이완제 등으로서 유용한 n-치환된 3-아자비시클로(3.2.0)헵탄 유도체 | |
CZ20004461A3 (cs) | Terapeutické činidlo |